{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:33:18Z","timestamp":1791894798450,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX22_3544"],"award-info":[{"award-number":["KYCX22_3544"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800303"],"award-info":[{"award-number":["2022YFD1800303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["JSSCTD202224"],"award-info":[{"award-number":["JSSCTD202224"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01138-5","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T07:21:35Z","timestamp":1746861695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cellular immune signatures and differences of four porcine circovirus type 2 vaccines to heterologous PCV2d infection"],"prefix":"10.1038","volume":"10","author":[{"given":"Shuai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"1138_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","volume":"1","author":"X-J Meng","year":"2013","unstructured":"Meng, X.-J. Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system. Annu. Rev. Anim. Biosci. 1, 43\u201364 (2013).","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"1138_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.virusres.2011.09.014","volume":"164","author":"T Opriessnig","year":"2012","unstructured":"Opriessnig, T. & Halbur, P. G. Concurrent infections are important for expression of porcine circovirus associated disease. Virus Res. 164, 20\u201332 (2012).","journal-title":"Virus Res."},{"key":"1138_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","volume":"164","author":"J Segal\u00e9s","year":"2012","unstructured":"Segal\u00e9s, J. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res. 164, 10\u201319 (2012).","journal-title":"Virus Res."},{"key":"1138_CR4","doi-asserted-by":"publisher","unstructured":"Ouyang, T., Zhang, X., Liu, X. & Ren, L. Co-Infection of Swine with Porcine Circovirus Type 2 and Other Swine Viruses. Viruses 11, https:\/\/doi.org\/10.3390\/v11020185 (2019).","DOI":"10.3390\/v11020185"},{"key":"1138_CR5","doi-asserted-by":"publisher","unstructured":"Guo, J. et al. Porcine Circovirus Type 2 Vaccines: Commercial Application and Research Advances. Viruses 14, https:\/\/doi.org\/10.3390\/v14092005 (2022).","DOI":"10.3390\/v14092005"},{"key":"1138_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tvjl.2012.06.031","volume":"194","author":"C Chae","year":"2012","unstructured":"Chae, C. Commercial porcine circovirus type 2 vaccines: efficacy and clinical application. Vet. J. (Lond., Engl. : 1997) 194, 151\u2013157 (2012).","journal-title":"Vet. J. (Lond., Engl. : 1997)"},{"key":"1138_CR7","doi-asserted-by":"publisher","unstructured":"Franzo, G. & Segal\u00e9s, J. Porcine Circovirus 2 Genotypes, Immunity and Vaccines: Multiple Genotypes but One Single Serotype. Pathogens 9, https:\/\/doi.org\/10.3390\/pathogens9121049 (2020).","DOI":"10.3390\/pathogens9121049"},{"key":"1138_CR8","doi-asserted-by":"publisher","unstructured":"Maity, H. K., Samanta, K., Deb, R. & Gupta, V. K. Revisiting Porcine Circovirus Infection: Recent Insights and Its Significance in the Piggery Sector. Vaccines 11, https:\/\/doi.org\/10.3390\/vaccines11081308 (2023).","DOI":"10.3390\/vaccines11081308"},{"key":"1138_CR9","doi-asserted-by":"publisher","first-page":"101790","DOI":"10.1016\/j.mcp.2022.101790","volume":"61","author":"Y Jia","year":"2022","unstructured":"Jia, Y. et al. Detection and genetic characteristics of porcine circovirus type 2 and 3 in Henan province of China. Mol. Cell. Probes 61, 101790 (2022).","journal-title":"Mol. Cell. Probes"},{"key":"1138_CR10","doi-asserted-by":"publisher","unstructured":"Rudova, N. et al. Genetic Diversity of Porcine Circovirus 2 in Wild Boar and Domestic Pigs in Ukraine. Viruses 14, https:\/\/doi.org\/10.3390\/v14050924 (2022).","DOI":"10.3390\/v14050924"},{"key":"1138_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.vetmic.2019.03.002","volume":"231","author":"KH Park","year":"2019","unstructured":"Park, K. H. et al. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge. Vet. Microbiol. 231, 87\u201392 (2019).","journal-title":"Vet. Microbiol."},{"key":"1138_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.vetmic.2012.12.019","volume":"163","author":"T Opriessnig","year":"2013","unstructured":"Opriessnig, T., Xiao, C.-T., Gerber, P. F. & Halbur, P. G. Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2. Vet. Microbiol. 163, 177\u2013183 (2013).","journal-title":"Vet. Microbiol."},{"key":"1138_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.meegid.2015.05.023","volume":"33","author":"N Ramos","year":"2015","unstructured":"Ramos, N., Mirazo, S., Castro, G. & Arbiza, J. First identification of Porcine Circovirus Type 2b mutant in pigs from Uruguay. Infect. Genet. Evol. 33, 320\u2013323 (2015).","journal-title":"Infect. Genet. Evol."},{"key":"1138_CR14","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s00705-014-2164-6","volume":"159","author":"HW Seo","year":"2014","unstructured":"Seo, H. W. et al. Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea. Arch. Virol. 159, 3107\u20133111 (2014).","journal-title":"Arch. Virol."},{"key":"1138_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s44149-021-00027-3","volume":"1","author":"R Shi","year":"2021","unstructured":"Shi, R., Hou, L. & Liu, J. Host immune response to infection with porcine circoviruses. Anim. Dis. 1, 23 (2021).","journal-title":"Anim. Dis."},{"key":"1138_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1128\/CVI.00418-10","volume":"18","author":"BR Trible","year":"2011","unstructured":"Trible, B. R. et al. Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease. Clin. Vaccin. Immunol. 18, 749\u2013757 (2011).","journal-title":"Clin. Vaccin. Immunol."},{"key":"1138_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/vim.2005.18.333","volume":"18","author":"P Meerts","year":"2005","unstructured":"Meerts, P., Van Gucht, S., Cox, E., Vandebosch, A. & Nauwynck, H. J. Correlation between type of adaptive immune response against porcine circovirus type 2 and level of virus replication. Viral Immunol. 18, 333\u2013341 (2005).","journal-title":"Viral Immunol."},{"key":"1138_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1746-6148-2-6","volume":"2","author":"P Meerts","year":"2006","unstructured":"Meerts, P. et al. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet. Res. 2, 6 (2006).","journal-title":"BMC Vet. Res."},{"key":"1138_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.vetmic.2007.06.004","volume":"125","author":"M Fort","year":"2007","unstructured":"Fort, M., Olvera, A., Sibila, M., Segal\u00e9s, J. & Mateu, E. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet. Microbiol. 125, 244\u2013255 (2007).","journal-title":"Vet. Microbiol."},{"key":"1138_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.vetmic.2005.04.010","volume":"108","author":"F Ostanello","year":"2005","unstructured":"Ostanello, F. et al. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus. Vet. Microbiol. 108, 179\u2013186 (2005).","journal-title":"Vet. Microbiol."},{"key":"1138_CR21","first-page":"1347","volume":"12","author":"NE McKeown","year":"2005","unstructured":"McKeown, N. E. et al. Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. Clin. Diagn. Lab. Immunol. 12, 1347\u20131351 (2005).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"1138_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.vetimm.2010.03.025","volume":"136","author":"T Kekarainen","year":"2010","unstructured":"Kekarainen, T. et al. Immune responses and vaccine-induced immunity against Porcine circovirus type 2. Vet. Immunol. Immunop 136, 185\u2013193 (2010).","journal-title":"Vet. Immunol. Immunop"},{"key":"1138_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2460\/ajvr.2002.63.354","volume":"63","author":"GM Rodr\u00edguez-Arrioja","year":"2002","unstructured":"Rodr\u00edguez-Arrioja, G. M. et al. Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome. Am. J. Vet. Res. 63, 354\u2013357 (2002).","journal-title":"Am. J. Vet. Res."},{"key":"1138_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2460\/ajvr.2004.65.88","volume":"65","author":"M Sibila","year":"2004","unstructured":"Sibila, M. et al. Use of a polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome. Am. J. Vet. Res. 65, 88\u201392 (2004).","journal-title":"Am. J. Vet. Res."},{"key":"1138_CR25","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1128\/JVI.78.12.6297-6303.2004","volume":"78","author":"M Fenaux","year":"2004","unstructured":"Fenaux, M., Opriessnig, T., Halbur, P. G., Elvinger, F. & Meng, X. J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J. Virol. 78, 6297\u20136303 (2004).","journal-title":"J. Virol."},{"key":"1138_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13567-015-0157-4","volume":"46","author":"HC Koinig","year":"2015","unstructured":"Koinig, H. C. et al. PCV2 vaccination induces IFN-\u03b3\/TNF-\u03b1 co-producing T cells with a potential role in protection. Vet. Res. 46, 20 (2015).","journal-title":"Vet. Res."},{"key":"1138_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1746-6148-5-45","volume":"5","author":"E Steiner","year":"2009","unstructured":"Steiner, E., Balmelli, C., Gerber, H., Summerfield, A. & McCullough, K. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. BMC Vet. Res. 5, 45 (2009).","journal-title":"BMC Vet. Res."},{"key":"1138_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.vetmic.2010.12.008","volume":"149","author":"P Martelli","year":"2011","unstructured":"Martelli, P. et al. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet. Microbiol. 149, 339\u2013351 (2011).","journal-title":"Vet. Microbiol."},{"key":"1138_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.vetimm.2008.12.024","volume":"129","author":"M Fort","year":"2009","unstructured":"Fort, M. et al. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet. Immunol. Immunop. 129, 101\u2013107 (2009).","journal-title":"Vet. Immunol. Immunop."},{"key":"1138_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1297-9716-45-44","volume":"45","author":"L Ferrari","year":"2014","unstructured":"Ferrari, L., Borghetti, P., De Angelis, E. & Martelli, P. Memory T cell proliferative responses and IFN-\u03b3 productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease. Vet. Res. 45, 44 (2014).","journal-title":"Vet. Res."},{"key":"1138_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder, R. A., Darrah, P. A. & Roederer, M. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8, 247\u2013258 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"1138_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1297-9716-44-18","volume":"44","author":"K Reutner","year":"2013","unstructured":"Reutner, K. et al. CD27 expression discriminates porcine T helper cells with functionally distinct properties. Vet. Res. 44, 18 (2013).","journal-title":"Vet. Res."},{"key":"1138_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-animal-013120-044226","volume":"10","author":"W Gerner","year":"2022","unstructured":"Gerner, W., Mair, K. H. & Schmidt, S. Local and Systemic T Cell Immunity in Fighting Pig Viral and Bacterial Infections. Annu. Rev. Anim. Biosci. 10, 349\u2013372 (2022).","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"1138_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40813-015-0012-z","volume":"1","author":"T Kekarainen","year":"2015","unstructured":"Kekarainen, T. & Segal\u00e9s, J. Porcine circovirus 2 immunology and viral evolution. Porcine Health Manag. 1, 17 (2015).","journal-title":"Porcine Health Manag."},{"key":"1138_CR35","doi-asserted-by":"publisher","unstructured":"Karuppannan, A. K. & Opriessnig, T. Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology. Viruses 9, https:\/\/doi.org\/10.3390\/v9050099 (2017).","DOI":"10.3390\/v9050099"},{"key":"1138_CR36","doi-asserted-by":"publisher","unstructured":"Kim, E. H. et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. Elife 9, https:\/\/doi.org\/10.7554\/eLife.52687 (2020).","DOI":"10.7554\/eLife.52687"},{"key":"1138_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.rvsc.2014.04.007","volume":"97","author":"HW Seo","year":"2014","unstructured":"Seo, H. W., Lee, J., Han, K., Park, C. & Chae, C. Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines. Res. Vet. Sci. 97, 38\u201342 (2014).","journal-title":"Res. Vet. Sci."},{"key":"1138_CR38","doi-asserted-by":"publisher","first-page":"940047","DOI":"10.3389\/fimmu.2022.940047","volume":"13","author":"W Lee","year":"2022","unstructured":"Lee, W. & Suresh, M. Vaccine adjuvants to engage the cross-presentation pathway. Front. Immunol. 13, 940047 (2022).","journal-title":"Front. Immunol."},{"key":"1138_CR39","doi-asserted-by":"crossref","unstructured":"Mishra, N. et al. in Smart Polymeric Nano-Constructs in Drug Delivery (eds Suresh P. Vyas, Udita Agrawal, & Rajeev Sharma) 151\u2013186 (Academic Press, 2023).","DOI":"10.1016\/B978-0-323-91248-8.00003-9"},{"key":"1138_CR40","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1016\/j.vaccine.2021.08.013","volume":"39","author":"C Venegas-Vargas","year":"2021","unstructured":"Venegas-Vargas, C. et al. Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a\/PCV2b) and challenge with virulent PCV2d. Vaccine 39, 5615\u20135625 (2021).","journal-title":"Vaccine"},{"key":"1138_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tvjl.2014.02.002","volume":"200","author":"HW Seo","year":"2014","unstructured":"Seo, H. W., Han, K., Park, C. & Chae, C. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines. Vet. J. 200, 65\u201370 (2014).","journal-title":"Vet. J."},{"key":"1138_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.vaccine.2016.11.085","volume":"35","author":"T Opriessnig","year":"2017","unstructured":"Opriessnig, T. et al. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to na\u00efve pigs under experimental conditions. Vaccine 35, 248\u2013254 (2017).","journal-title":"Vaccine"},{"key":"1138_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF01310989","volume":"96","author":"I Tischer","year":"1987","unstructured":"Tischer, I., Peters, D., Rasch, R. & Pociuli, S. Replication of porcine circovirus: induction by glucosamine and cell cycle dependence. Arch. Virol. 96, 39\u201357 (1987).","journal-title":"Arch. Virol."},{"key":"1138_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/tbed.13026","volume":"66","author":"N Chen","year":"2019","unstructured":"Chen, N. et al. A novel NADC30-like porcine reproductive and respiratory syndrome virus (PRRSV) plays a limited role in the pathogenicity of porcine circoviruses (PCV2 and PCV3) and PRRSV co-infection. Transbound. Emerg. Dis. 66, 28\u201334 (2019).","journal-title":"Transbound. Emerg. Dis."},{"key":"1138_CR45","doi-asserted-by":"publisher","unstructured":"Li, S. et al. A potent CD8 T-cell response may be associated with partial cross-protection conferred by an attenuated Chinese HP-PRRSV vaccine against NADC30-like PRRSV challenge. J. Gen. Virol. 104, https:\/\/doi.org\/10.1099\/jgv.0.001850 (2023).","DOI":"10.1099\/jgv.0.001850"},{"key":"1138_CR46","doi-asserted-by":"publisher","first-page":"1328177","DOI":"10.3389\/fmicb.2024.1328177","volume":"15","author":"Y Tian","year":"2024","unstructured":"Tian, Y. et al. Immune cell early activation, apoptotic kinetic, and T-cell functional impairment in domestic pigs after ASFV CADC_HN09 strain infection. Front. Microbiol. 15, 1328177 (2024).","journal-title":"Front. Microbiol."},{"key":"1138_CR47","doi-asserted-by":"publisher","first-page":"e0200223","DOI":"10.1128\/jvi.02002-23","volume":"98","author":"S Mu","year":"2024","unstructured":"Mu, S. et al. Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV through swine DC vaccination. J. Virol. 98, e0200223 (2024).","journal-title":"J. Virol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01138-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T20:03:35Z","timestamp":1746907415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01138-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1138"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01138-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}